Avient Corporation

AI-generated fair value estimate for this company.

Method: 10-year unlevered FCF DCF. FCF base ~$193M (FY2025 FCF $195M; TTM through Jun-2026 $190.8M). Growth 6% per year years 1-5 (continued specialty-formulation mix shift and margin recovery), 3.5% per year years 6-10. Discount rate 9%. Terminal growth 2.5%. Sum of PV of years 1-10 FCF ~$1,609M; terminal value discounted ~$2,043M; enterprise value ~$3,652M. Less net debt of $1,450M gives equity value ~$2,202M. Divided by ~92M diluted shares gives ~$23.93/share.

Reasoning: Avient is a mature, diversified specialty-polymers/formulations producer with steady but modest organic growth and analyst-flagged near-term margin expansion, making a phased FCF DCF appropriate; a 9% discount rate reflects moderate leverage (roughly 2.5-3x net debt/EBITDA) and cyclical industrial end-markets.